fda glp-1 news november 2025 Beyond the Headlines: Warning Letters to Compounders Lilly, chasing Novo, expects second-quarter

Plaintiffs claim that internal documents, marketing materials, and medical literature demonstrate that these manufacturers were aware of the potential dangers but continued to promote the formulas for vulnerable infants

Network pharmacology can decode the mechanisms of drug action with an overall view point, with the focus changing from "single protein target, single drug" to "multiple protein targets, multiple drugs"[7]

They became broadly available as a result of the drug shortage declared in 2022, but that legal foundation has since eroded

Which Route Should You Choose for Your Goal

However, PFOS has attracted considerable attention because of its toxicity in various biological systems and to organisms including humans 1